Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial

Background Monitoring of patient outcomes in multiple sclerosis (MS) is fundamental for individualized treatment decisions. So far, these decisions have been motivated by conventional outcomes, i.e., relapses or clinical disability supported by radiological disease activity. Complementing this conce...

Full description

Bibliographic Details
Main Authors: Patrick Altmann, Markus Ponleitner, Tobias Monschein, Nik Krajnc, Gudrun Zulehner, Tobias Zrzavy, Fritz Leutmezer, Paulus Stefan Rommer, Barbara Kornek, Thomas Berger, Gabriel Bsteh
Format: Article
Language:English
Published: SAGE Publishing 2022-11-01
Series:Digital Health
Online Access:https://doi.org/10.1177/20552076221135387